InspireMD Inc

Research InspireMD Inc (NSPR) on Bullrun: market cap USD 43.17M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Valuation Snapshot

latest market cap is USD 43.17M.

Five-year financial history

YearRevenueNet incomeFree cash flowGross marginDiluted EPSCashTotal debtEquity
FY2025USD 8.98M-USD 48.79M-USD 36.77M29.5%-0.76USD 8.94MUSD 3.29MUSD 55.20M
FY2024USD 7.01M-USD 32.01M-USD 23.27M21.5%-0.76USD 18.92MUSD 2.34MUSD 36.09M
FY2023USD 6.21M-USD 19.92M-USD 16.76M29.1%-0.82USD 9.64MUSD 1.60MUSD 39.50M
FY2022USD 5.17M-USD 18.49M-USD 16.02M21.6%-2.35USD 4.63MUSD 1.35MUSD 17.39M

Valuation history

YearSnapshot dateMarket capP/EDividend yieldAnnual dividend/share
20262026-08-25USD 43.17Mn/an/an/a
20252025-12-31USD 77.49Mn/an/an/a
20242024-12-31USD 69.99Mn/an/an/a
20232023-12-29USD 60.55Mn/an/an/a
20222022-12-30USD 7.17Mn/an/an/a
20212021-12-31USD 25.05Mn/an/an/a

About InspireMD Inc

InspireMD, Inc., a medical device company, focuses on the development and commercialization of products for the treatment of carotid artery disease and other vascular conditions in the United States, Germany, Italy, Russia, Poland, and internationally. It offers MicroNet, a biocompatible polymer mesh material for medical implants, as well as for treating plaque prolapse and embolization; CGuard carotid embolic prevention system (EPS) for use in carotid artery applications; CGuard Prime Carotid Stent System;

Related stock research

Other Healthcare stocks

Frequently asked questions

What is InspireMD Inc's market cap?

InspireMD Inc's market capitalization is USD 43.17M.

What does InspireMD Inc do?

InspireMD, Inc., a medical device company, focuses on the development and commercialization of products for the treatment of carotid artery disease and other vascular conditions in the United States, Germany, Italy, Russia, Poland, and internationally.